CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology biotechnology company focused on developing and commercializing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced the appointment of Chan Lee as General Counsel, effective July 18, 2022. Mr. Lee joins … [Read more…]
MADISON, Wis., & LEHI, Utah–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, and CivicaScript,TM a statutory public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, announced today that Navitus has joined CivicaScript as a founding member. This … [Read more…]
NEW YORK–(BUSINESS WIRE)–Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. Haggstrom brings an extensive background in medical device commercialization and product launches, with a technical background in R&D engineering, holding over 20 U.S. patents. “I am honored and excited to join the Synchron team and … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AAIC2022—Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, today announced the acceptance of two research abstracts and an oral presentation at the Alzheimer’s Association International Conference® 2022 (AAIC®). The largest international meeting dedicated to advancing dementia science, AAIC will be held as an online and in-person event in San … [Read more…]
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8006, an antibody drug conjugate (ADC) that targets folic acid receptor α (FRα). The clinical trial is a multicenter, open-label Phase 1 clinical study in patients with advanced solid tumors to … [Read more…]
Series Spotlights the RenovoRx Journey, its Leadership and Innovative Treatment Platform Targeting Difficult-to-Treat Cancers LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced the launch of a new video series – The RenovoRx Story. This video series provides viewers with a unique … [Read more…]
MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, the leading data management platform for biomedical research and collaboration, is adding two new solutions to its product suite. The tools will give researchers new ways to streamline clinical trials, plus discover patient cohorts and analyze data on an enterprise scale. Flywheel Trial Flow is Flywheel’s data management platform for compliant clinical data … [Read more…]
SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.–(BUSINESS WIRE)–#EHR—Tebra, the digital backbone for independent healthcare practices, announced that Kevin Marasco has joined the company as Chief Marketing Officer. Kevin will lead the marketing team and report directly to CEO Dan Rodrigues. As CMO, he will lead all aspects … [Read more…]
Premium heart rate strap will now track pace and distance during indoor runs, giving athletes even more data to push their limits OLATHE, Kan.–(BUSINESS WIRE)–Garmin® International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the HRM-Pro™ Plus, a premium heart rate strap that adds pace and distance data while continuing to provide athletes … [Read more…]
Webcast of Capital Markets Day on August 3 will include discussion of fiscal fourth-quarter results ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results the evening of August 2. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its capital markets … [Read more…]
